IRIS
MEGNA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.204
EU - Europa 9.044
NA - Nord America 7.212
SA - Sud America 1.731
AF - Africa 301
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 30.522
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.915
SG - Singapore 6.420
RU - Federazione Russa 4.393
CN - Cina 2.874
DE - Germania 1.814
BR - Brasile 1.441
IT - Italia 1.210
HK - Hong Kong 1.076
VN - Vietnam 675
IN - India 420
NL - Olanda 319
KR - Corea 266
GB - Regno Unito 219
FI - Finlandia 201
FR - Francia 193
IE - Irlanda 153
CA - Canada 127
AR - Argentina 121
MX - Messico 114
UA - Ucraina 99
CI - Costa d'Avorio 83
ZA - Sudafrica 81
BD - Bangladesh 75
PL - Polonia 74
SE - Svezia 73
ES - Italia 72
JP - Giappone 59
EC - Ecuador 54
AT - Austria 49
TR - Turchia 48
ID - Indonesia 47
IQ - Iraq 40
BG - Bulgaria 29
PK - Pakistan 29
CO - Colombia 27
MA - Marocco 27
LT - Lituania 24
PY - Paraguay 23
VE - Venezuela 20
KE - Kenya 17
CL - Cile 16
SA - Arabia Saudita 15
AU - Australia 14
PE - Perù 14
BE - Belgio 13
UZ - Uzbekistan 13
CZ - Repubblica Ceca 12
GR - Grecia 12
RO - Romania 12
TW - Taiwan 12
CH - Svizzera 11
EG - Egitto 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
OM - Oman 10
UY - Uruguay 10
DK - Danimarca 9
DZ - Algeria 9
IL - Israele 9
IR - Iran 9
RS - Serbia 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
PA - Panama 8
PH - Filippine 8
BB - Barbados 7
MY - Malesia 7
NP - Nepal 7
TH - Thailandia 7
AL - Albania 5
CR - Costa Rica 5
CY - Cipro 5
EE - Estonia 5
GT - Guatemala 5
KH - Cambogia 5
PT - Portogallo 5
SN - Senegal 5
AM - Armenia 4
BO - Bolivia 4
CG - Congo 4
ET - Etiopia 4
EU - Europa 4
HR - Croazia 4
HU - Ungheria 4
LB - Libano 4
LY - Libia 4
NI - Nicaragua 4
SC - Seychelles 4
BH - Bahrain 3
BY - Bielorussia 3
GH - Ghana 3
GN - Guinea 3
JM - Giamaica 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MK - Macedonia 3
MR - Mauritania 3
NC - Nuova Caledonia 3
Totale 30.434
Salva come PNG Salva come JPEG
Città #
Singapore 3.122
Hefei 1.311
Moscow 1.135
Hong Kong 1.063
Ashburn 746
Chandler 687
Beijing 619
Santa Clara 589
Krefeld 387
Los Angeles 264
Seoul 255
Ho Chi Minh City 252
Amsterdam 243
Kochi 222
Naples 213
Napoli 188
Boston 174
Bad Bellingen 171
Millbury 168
Redondo Beach 158
Dallas 156
Lawrence 146
Buffalo 137
Des Moines 131
São Paulo 127
Hanoi 115
Munich 114
San Jose 110
The Dalles 110
New York 109
Nanjing 85
Seattle 79
Helsinki 70
Milan 70
Wilmington 64
Mexico City 63
Princeton 58
Rome 58
Houston 57
Brooklyn 56
Dublin 56
Frankfurt am Main 55
Tokyo 53
Falkenstein 52
Warsaw 49
Rio de Janeiro 48
Chicago 46
Dong Ket 44
Montreal 44
Turku 44
Düsseldorf 43
Orem 43
Fairfield 42
London 42
Chennai 41
Boardman 40
Lappeenranta 38
Guangzhou 36
Nuremberg 36
Menlo Park 34
Denver 33
Poplar 32
San Francisco 32
Stockholm 32
Washington 31
Johannesburg 30
Woodbridge 30
Atlanta 28
Belo Horizonte 28
Nanchang 28
Council Bluffs 27
Kronberg 27
Sofia 27
Phoenix 26
Biên Hòa 24
Brasília 23
Curitiba 23
Arezzo 22
Da Nang 22
Ottawa 22
Haiphong 21
Pune 21
Campinas 20
Lauterbourg 20
Porto Alegre 20
Shenyang 20
Toronto 20
Ankara 19
Bengaluru 19
Guayaquil 18
Shanghai 18
Tianjin 18
Hebei 17
Manchester 17
Mumbai 17
Nairobi 17
Paris 17
Vienna 17
Buenos Aires 16
Quito 16
Totale 15.683
Salva come PNG Salva come JPEG
Nome #
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study 373
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 369
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis) 354
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 349
A case of aquagenic wrinkling of the palms 227
Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists 164
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 158
An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy- a new subtype? 153
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications 151
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 150
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence 144
Psoriasis and sport: a new ally? 144
"Active" photoprotection: sunscreens with DNA repair enzymes. A review of the literature 140
Generalized Pustular Psoriasis rapidly and successfully treated with Ixekizumab in a Caucasian patient 135
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool? 133
Efficacy and safety of risankizumab in psoriasis patients who failed anti‐IL‐17, anti‐12/23 and/or anti IL‐23: preliminary data of a real‐life 16‐week retrospective study 127
What's new about atopic dermatitis and sporting activity 124
Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist 124
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma 124
Psoriasis Features in Patients with Inflammatory Bowel Disease 118
Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatment 117
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study 116
Adult atopic dermatitis: a review 116
Persistent candidiasis infection during anti‐ IL ‐17 treatment for plaque psoriasis requiring biologic discontinuation: a case series and literature review 115
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 115
Tattooing and hidradenitis suppurativa: stigmatization and camouflage 114
Infantile Acute Generalized Pustular Psoriasis: A Case Report 114
Cutaneous leucocytoclastic vasculitis during secukinumab treatment 114
QuantiFERON TB‐gold conversion rate among psoriasis patients under biologics: a 9‐year retrospective study 114
Systemic treatment for psoriasis and malignancies: A real risk? 112
L'avvento degli inibitori delle proteasi nella terapia dell'infezione da epatite C: Reazioni avverse dermatologiche 111
Photodynamic Therapy and Skin Appendage Disorders: A Review 111
Chronic inducible urticarias in children 111
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: report of two cases 111
The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature 111
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab 110
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 110
Cutaneus sarcoidosis small-fiber neuropathy resembling leprosy: a case report 110
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 110
A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation 110
Appearances may be deceiving 109
Psoriasis in a cohort of patients with common variable immunodeficiency 109
Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient 109
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears 108
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge 107
Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. 107
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 106
A case of linear psoriasis in a young patient with Down syndrome and review of the literature 106
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 106
Chronic hand Eczema: Is IL-36á helpful in diagnosis and classification? 106
Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab 105
Corrigendum: A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab (Clin Cosmet Investig Dermatol. (2023), 16, (3503–3507), 10.2147/CCID.S447123) 105
Skin diseases and visual arts 105
Psoriatic arthritis and psoriasis: differential diagnosis 105
Pyoderma gangrenosum successfully treated with topical tacrolimus 105
Neutrophilic dermatosis in pregnancy: An uncommon course 105
Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis 105
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 105
Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features 104
Erythrodermic Pityriasis Rubra Pilaris treatment: two case reports and literature review 104
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency 104
Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role? 104
Risk Factors for Psoriasis Flares: A Narrative Review 103
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 103
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection 103
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 103
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 103
Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience 103
Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1‐year period 102
Irisin, a novel metabolic biomarker in hidradenitis suppurativa: correlation with clinical responsivity to anti-TNF-α therapy 101
Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas 101
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 101
Anterior Cervical Hypertrichosis: A Case Report and Review of the Literature. 101
Psoriasis in elderly and non elderly population: clinical and molecular features. 101
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 101
A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy 100
Dermoscopic patterns of intradermal naevi 100
16-year real-life study on the prevalence of mycoses in a paediatric population 100
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis 99
A multidisciplinary care unit approach for the management of psoriatic arthritis: an Italian experience 99
Desmosomes in heart and skin: friends or foes? 99
Insulin Resistance and Skin Diseases 99
Giant nodular melanoma of the nose in a 78‐year old female refusing complete excision 99
Management of Psoriasis Patients with Serious Infectious Diseases 98
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study 98
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature 98
Efficacy of JAK inhibitors in the treatment of psoriasiform atopic dermatitis 98
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 98
Ixekizumab: an efficacious treatment for both psoriasis and hidradenitis suppurativa 98
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature 97
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation? 97
The use of ChatGPT in the dermatological field: a narrative review 97
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI) 97
Garbage and skin diseases related risk. 97
Adalimumab Biosimilar Efficacy and Safety in a 5-Year-Old Patient with Severe Plaque Psoriasis During SARS-CoV-2 Pandemic Outbreak 96
A case of Paediatric Acrodermatitis Continua of Hallopeau successfully treated with adalimumab biosimilar 96
Skin diseases and tattoos: A five-year experience 96
QuantiFERON TB-gold conversion is not uncommon in psoriasis patients under anti-TNF-α 96
Anti‐interleukin‐23 for psoriasis in elderly: guselkumab, risankizumab and tildrakizumab in real world practice 96
Risankizumab treatment in psoriasis patients who failed anti-IL17: a 52-week real-life study 96
Totale 12.112
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021412 0 0 0 0 0 0 28 161 94 27 43 59
2021/20221.301 22 32 21 44 39 52 30 92 155 103 219 492
2022/20232.027 234 168 66 93 211 201 72 207 311 254 165 45
2023/20243.132 101 238 225 143 111 213 58 187 1.287 73 344 152
2024/202510.538 468 590 81 85 266 587 980 769 802 1.378 3.645 887
2025/202612.713 2.170 2.269 2.190 2.030 3.066 798 190 0 0 0 0 0
Totale 31.164